GROUP ONE TRADING, L.P. - CYTOSORBENTS CORP ownership

CYTOSORBENTS CORP's ticker is CTSO and the CUSIP is 23283X206. A total of 53 filers reported holding CYTOSORBENTS CORP in Q3 2023. The put-call ratio across all filers is 0.95 and the average weighting 0.1%.

Quarter-by-quarter ownership
GROUP ONE TRADING, L.P. ownership history of CYTOSORBENTS CORP
ValueSharesWeighting
Q2 2023$15,304
-48.2%
4,263
-51.4%
0.00%
Q1 2023$29,531
+105367.9%
8,763
+48583.3%
0.00%
Q4 2022$28
-98.6%
18
-98.9%
0.00%
Q3 2022$2,000
-50.0%
1,6540.0%0.00%
Q2 2022$4,000
-69.2%
1,6540.0%0.00%
Q3 2021$13,000
-74.5%
1,654
-75.1%
0.00%
Q1 2020$51,000
+2450.0%
6,648
+1595.9%
0.00%
Q3 2019$2,000
+100.0%
392
+326.1%
0.00%
Q2 2019$1,0000.0%920.0%0.00%
Q1 2019$1,000
-97.4%
92
-98.0%
0.00%
Q4 2018$38,000
-40.6%
4,664
-6.6%
0.00%
-100.0%
Q3 2018$64,000
-45.3%
4,991
-51.2%
0.00%0.0%
Q2 2018$117,000
+5750.0%
10,221
+3924.0%
0.00%
Q3 2017$2,000
-89.5%
254
-94.3%
0.00%
Q2 2017$19,000
-34.5%
4,454
-29.9%
0.00%
Q1 2017$29,000
+314.3%
6,354
+369.3%
0.00%
Q4 2016$7,000
-12.5%
1,354
+8.0%
0.00%
Q3 2016$8,0001,2540.00%
Other shareholders
CYTOSORBENTS CORP shareholders Q3 2023
NameSharesValueWeighting ↓
CM Management, LLC 675,000$918,0001.02%
Sargent Investment Group, LLC 1,108,233$2,028,0000.63%
Skylands Capital, LLC 2,347,034$3,192,0000.52%
JACOB ASSET MANAGEMENT OF NEW YORK LLC 253,000$344,0000.37%
Avenir Corp 2,314,854$3,148,0000.33%
Granahan Investment Management 1,511,029$2,055,0000.07%
ACT CAPITAL MANAGEMENT, LLC 35,000$48,0000.07%
Winning Points Advisors, LLC 22,900$33,0000.04%
Cowen Prime Advisors LLC 42,200$57,0000.03%
Seelaus Asset Management LLC 23,900$33,0000.03%
View complete list of CYTOSORBENTS CORP shareholders